Understanding Second Trimester Pregnancy Loss and Its Prevalence

Second trimester pregnancy loss (STPL), often referred to as late miscarriage, occurs between 12 or 13 weeks and 24 weeks of gestation. This heartbreaking event affects an estimated 3 to 4 percent of all pregnancies in the UK and Ireland, translating to thousands of families each year facing profound grief. Unlike first-trimester losses, which are more common and often discussed, STPL comes at a stage when many parents feel a sense of security after passing the initial high-risk period. The emotional toll is immense, compounded by physical recovery challenges and uncertainties about future pregnancies.

Women experiencing STPL may present with symptoms like vaginal bleeding, abdominal pain, or reduced fetal movements. Diagnosis typically involves ultrasound confirmation of no fetal heartbeat or other indicators of demise. The process can involve expectant management, medical induction, or surgical options, but as recent research highlights, these pathways are far from uniform across regions.

The PASTeL Research Programme: Pioneering Insights from University of Aberdeen

The University of Aberdeen has taken a leading role in addressing these gaps through its PASTeL (Pregnancy After Second Trimester Loss) research programme. This initiative, housed within the Aberdeen Centre for Women's Health Research, encompasses multiple studies aimed at improving outcomes for affected families. PASTeL-1 explored incidence using local data, PASTeL-2 examined subsequent pregnancy risks, and the latest PASTeL-3 survey directly tackles care variations.

Led by Dr. Andrea Woolner, a Senior Clinical Lecturer at the University of Aberdeen and Honorary Consultant at NHS Grampian, the programme collaborates with institutions like the University of Manchester, University College Cork, and University of Birmingham. Funded by Tommy's, the pregnancy charity, this academic effort underscores how university-led research drives real-world healthcare improvements. For those interested in contributing to such vital work, opportunities abound in research jobs within higher education.

Key Findings from the PASTeL-3 Survey: A Snapshot of Disparities

The PASTeL-3 study, published in the European Journal of Obstetrics & Gynecology and Reproductive Biology, surveyed 116 healthcare professionals across UK and Ireland maternity services. Responses revealed stark inconsistencies dubbed a 'postcode lottery,' where care quality depends on location rather than need. Definitions of STPL lacked consensus, with varying gestational age cutoffs complicating data collection and service planning.

Dr. Woolner emphasized, "Pregnancy loss at any stage is devastating. This study showed a lack of research and evidence-based clinical practice around STPL." Professor Alex Heazell from the University of Manchester added that prior audits confirmed fragmented care, urging better data for optimal support.

Variations in Definitions and Diagnostic Approaches

One core issue is the absence of a standardized definition. While most align STPL with losses before 24 weeks, exact starting points (12 vs. 13 weeks) and terminology differ, leading to mismatched statistics and protocols. About 43 percent of units allow self-referral for second-trimester assessments, but this varies regionally, potentially delaying care in some areas.

Post-mortem examinations, crucial for identifying causes like chromosomal anomalies or infections, are routine in only 52 percent of units. This gap hinders learning and prevention efforts, highlighting the need for national guidelines to ensure equitable investigations.

Treatment Inconsistencies: The Misoprostol Dosage Dilemma

Medical management dominates, with misoprostol used to induce expulsion. Yet, dosages range wildly from 50 to 400 micrograms, and 63 percent of clinicians reported uncertainty over the optimal amount. This reflects sparse evidence, risking ineffective treatment or side effects like prolonged pain.

Surgical options like dilation and evacuation are rarely elective, reserved for complications. Third-stage management relies on oxytocics in most cases, though 10 percent use misoprostol alone. Such variability can prolong suffering; standardized dosing trials are urgently needed.University of Aberdeen Press Release

Photo by Polka w UK on Unsplash

• Expectant: Natural expulsion (variable success).
• Medical: Mifepristone priming followed by misoprostol.
• Surgical: For retained products or hemorrhage.

Care Delivery Locations and Infrastructure Challenges

Care isn't always in maternity wards; some hospitals use gynaecology or general areas, especially under 16-18 weeks. Bereavement suites, ideal for privacy, may be unavailable, forcing use of contingency spaces. This setup exacerbates trauma, as parents navigate shared environments during delivery.

Researchers call for infrastructure reviews, optimal referral pathways, and dedicated spaces. In academic health centers linked to universities like Aberdeen, integrated models show promise for better outcomes.

Follow-Up Care and Support for Subsequent Pregnancies

Follow-up occurs in nearly all units with consultants, but only 45 percent use dedicated pregnancy loss clinics. Instead, 43 percent direct to preterm birth clinics, despite not all STPL involving labor. For next pregnancies, 31 percent offer specialist loss clinics, vital given elevated risks like recurrence or preterm birth.

Over 80 percent of professionals feel confident in subsequent care, but structured support reduces anxiety. Tommy's advocates for universal bereavement pathways, akin to stillbirth protocols.Tommy's Charity

Emotional and Psychological Impacts on Families

STPL shatters expectations, triggering intense grief, guilt, PTSD, and depression. Parents report isolation, especially post-12 weeks when societal 'safety' narratives prevail. Mental health risks persist into future pregnancies, with heightened anxiety.

Bereavement support varies, underscoring needs for counseling, peer groups, and memory-making like hand/foot prints. University research informs holistic care, positioning academics as key to compassionate reforms. Explore higher ed career advice for roles in maternal health research.

Research Priorities and Calls for National Guidelines

Survey respondents prioritized: optimizing medical management (e.g., scarred uterus cases), reducing retained placenta risks, next-pregnancy impacts, and investigations. Dr. Jyotsna Vohra from Tommy's stressed, "We need more research and better standardised care across the NHS."

Developing evidence-based guidelines, like those for stillbirth, could eliminate the postcode lottery. Universities must lead trials and data collection.PASTeL-3 Study DOI

The Role of Higher Education in Advancing Maternal Healthcare

Institutions like the University of Aberdeen exemplify how higher education bridges research and policy. By surveying frontline workers, academics expose systemic flaws, advocating change. This work attracts talent to higher ed jobs in obstetrics and public health.

Collaborations foster multi-site data, essential for rare events like STPL. Aspiring researchers can find research assistant jobs to contribute.

Photo by Seema Miah on Unsplash

Future Outlook: Towards Equitable STPL Care

Upcoming PASTeL phases will incorporate lived experiences, refining recommendations. Policymakers must fund dedicated clinics, training, and trials. Families deserve consistent, compassionate care regardless of postcode.

Check Rate My Professor for insights into leading academics, higher ed jobs for careers, and career advice for advancement. University jobs in the UK offer paths to impact health outcomes. Post a job to attract top talent.